To determine the significance of the proliferative activity of hepatocellular carcinoma (HCC), we studied the bromodeoxyuridine (BrdU) labeling index (L. I.) in 24 consecutive patients with HCC. The features of HCC such as tumor size, intrahepatic metastasis, vascular involvement, were not correlated with the BrdU L. I. Multivariate analysis revealed that the BrdU L. I. was a significant predictor of the disease-free survival time.
Since most patients with hepatocellular carcinoma (HCC) have liver dysfunction due to chronic hepatitis or liver cirrhosis, the treatment of HCC cannot be considered without reference to the patient's liver function before and after therapy1). Each therapeutic modality, including hepatectomy, chemotherapy, transcatheter arterial embolization, and ethanol injection, has the risk of possibly damaging or destroying non-cancerous liver. To determine whether patients should be given additional therapy for prophylaxis against recurrence, better prediction of the risk of recurrence is necessary. Various prognostic factors for HCC have been studied by many Attempts to characterize the proliferative activity of human tumors can be traced to the 1960s' and observation of the incorporation of tritiated thymidine7,8). Since then, bromodeoxyuridine (BrdU) incorporation has come to be utilized for this purpose. BrdU is an analogue of thymidine that is incorporated by cell in the S phase as tritiated thymidine9,10)
In the present, we investigated whether the BrdU L. I.
was a useful predictor of recurrence by long-term retrospective assessment of the clinical outcome.
Patients and methods
From April to October 1989, 24 patients (22 men and 2 women) who underwent hepatectomy for hepatocellular carcinoma at the Institute of Gastroenterology of Tokyo Women's Medical College were enrolled in this study. The patients were fully informed about the examinations and surgical procedures involved. Injection of 1000mg of BrdU (Takeda Pharmaceutical Co., Tokyo, Japan) was started via a cubital vein at the time of skin incision, and was continued for 30 minutes. After hepatectomy, tumor tissues were immediately removed and fixed in cold 70% ethanol overnight. Paraffin-embedded sections were used for immunohistochemical staining. The incorporated BrdU was stained with an anti-BrdU monoclonal antibody (Becton-Dickinson, Mountain View, CA) using the method described elsewhere11). In brief, deparaffinized sections were immersed in 4 N HCl for 20 minutes to denature DNA and then were rinsed in 0.1M Natetraborate for 5 minutes to neutralize HCl. Next, diluted (1:100) anti-BrdU antibody was applied to the slides. Immunohistochemical detection was done by the ABC method using diaminobenzidine tetrahydrochloride (DAB). The adjacent sections were stained with hematox- not correlate with tumor size (Fig . 2) . Regarding the Edmondson's Classification relationship with tumor differentiation according to Edmondson and Steiner, poorly differentiated HCC always had a BrdU L. I.>1%, while the value for well differentiated HCC were distributed widely (Fig. 3) . In addition, neither the macroscopic appearance nor the tissue type showed any relationship with the BrdU L. I. (Fig. 4) .
Intrahepatic metastasis (IM), portal vein involvement (Vp), capsular formation, and extracapsular invasion are believed to be signs of the progression of HCC. However, there was no significant relationship between these factors and the BrdU L. I. (Fig. 5 and 6 ). Since most of the factors investigated were rank order parameters, correlations were calculated using Spearman rank correlation method (Table 1 ). The parameters which showed a negative correlation with the BrdU L. I. were intrahepatic metastasis and lymph node metastasis, while there was a positive correlation with portal vein involvement, hepatic vein involvement, and cell density. Therefore, the BrdU L. I. was not correlated with classical pathological factors. Regarding the relationship between the BrdU L. I. and (p=0.0275 by the log-rank test). This suggested that recurrence would come later in the low BrdU L. I. group than in the high BrdU L. I. group. ratio, cell density, macroscopic appearance, and microscopic appearance were used as covariates. Among them, the BrdU L. I. and the presence of extracapuslar invasion remained significant covariates after the stepwise process.
In contrast, there were no significant covariates when analysis of the crude survival of curatively resected patients was performed. Based on these the patients were divided into a high BrdU L. I. (HB) group (>2%; n=7) and a low BrdU L. I. by the log-rank test). This suggested that the low BrdU L.I. group would survive longer than the high BrdU L . 1. group.
rates are shown in Fig. 7 . Disease-free survival was significantly better in the LB group than in the HB group (p= 0.0275; log-rank test) . All patients in the HB group showed recurrence within 2 .5 years compared with a 40% recurrence rate in the LB group . The survival rates of both groups are shown in Fig. 8 
